Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease. Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers.
Latest News
January 6, 2012Pearl Therapeutics Announces Successful...
December 8, 2011Pearl Therapeutics Reports Positive Phase...
October 28, 2011Pearl Therapeutics Presents New Scientific...
More Press Releases